MedTrace Logo

In Vitro Fertilization Impact on Metabolic Parameters

NCT03426228 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 344

Last updated 2021-07-14

Study results available
· View outcomes & findings →

Summary

A quantitative prospective cohort study will be conducted, where blood samples will be collected at different timings during the IVF protocol, to assess the impact of fertility medications on metabolic parameters of patients undergoing IVF treatment.

Conditions

Interventions

DIAGNOSTIC_TEST

HbA1C

After overnight fasting, 10 ml of blood will be collected at four different timings during the IVF protocol: 1. At baseline (second day of the menstrual period) 2. Triggering phase (post-egg retrieval procedure) 3. Embryo transfer phase (post-transfer procedure) 4. Week 4 (positive bHCG) 4\. Week 8 of pregnancy

Sponsors & Collaborators

  • Fakih IVF Fertility Center

    collaborator OTHER

  • University of Sharjah

    collaborator OTHER

  • University of Warwick

    lead OTHER

Principal Investigators

  • Ayla Coussa, Dietitian · Fakih IVF Dubai

Eligibility

Min Age
18 Years
Max Age
39 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-02-15
Primary Completion
2019-08-01
Completion
2020-01-05

Countries

  • United Arab Emirates

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03426228 on ClinicalTrials.gov